A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia
Clinical trial NCT00240708 · COMPLETED
Trial details
- NCT number
- NCT00240708
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.